The Access to Medicine Foundation is the research organization behind the Access to Medicine Index and the Antimicrobial Resistance Benchmark. The Index and the Benchmark rank and compare pharmaceutical companies on the basis of what they are doing to improve access to medicine and limit drug-resistant infections, respectively.

You can see here the companies covered by the Index and the companies covered by the Benchmark.

• The Access to Medicine Index 2018, Access to Medicine Foundation, 2018
• The Antimicrobial Benchmark 2018, Access to Medicine Foundation, 2018

As of March 2019, 86 institutional investors - collectively managing assets in excess of $11 trillion - have already signed the investor statement.